Limited Time

New Customer Offer

Save up to 48% off your first probiotic order!

Burst Save up to 40% with your HSA/FSA funds Save up to 40% with HSA/FSA
Learn more

Legal notice

We inform you that the Unified Patent Court on 8 October 2026 in a preliminary measure ordered us to refrain from infringing EP 2 753 187 B2 in any way, in particular by making, offering, placing on the market and/or using and/or importing or storing for those purposes products containing Eubacterium hallii (nowadays: Anaerobutyricum hallii) and/or Alcaligenes faecalis for use in the prevention or treatment of insulin resistance and/or related complications, including the products Glucose Control and Metabolic Daily, in Belgium, Denmark, Germany, France, Italy, the Netherlands, Sweden and Switzerland.

Pendulum put the 'pro' in probiotics

Doctor-formulated

Founded by PhD doctors and scientists from Johns Hopkins, Harvard, Berkeley, and Stanford

Clinical efficacy

Created Glucose Control, the only medical probiotic on the market clinically shown to improve A1C in type 2 diabetes

Proprietary strains

Featuring strains you can't get anywhere else, including live Akkermansia, a keystone strain that's been in 3,000+ scientific
publications

Cutting-edge research

We continue to drive microbiome research forward through our own rigorous research and partnerships in clinical trials

Revolutionary manufacturing

Next-generation anaerobic strains are manufactured in our own strict, oxygen-free facility in the U.S.

Our first investor and continuing research partner. We are the first consumer microbiome company to co-develop a registry with the Mayo Clinic.

Our team has served as board members for ADA chapters and the ADA Research Foundation. Pendulum was profiled at the annual Scientific Sessions.